DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C

Area of Science:

• Immunogenetics
• Hepatology
• Virology

Background:

• Chronic hepatitis C (CHC) poses a significant global health challenge.
• Understanding host genetic factors, like human leukocyte antigen (HLA) class II alleles, is crucial for predicting disease progression.
• The relationship between specific HLA class II antigens and liver disease severity in CHC patients requires further elucidation.

Purpose of the Study:

• To analyze the association between HLA class II antigens and the severity of liver disease in patients with chronic hepatitis C.
• To investigate the correlation of specific HLA DRB1 alleles with necroinflammatory activity and liver fibrosis progression in CHC.

Main Methods:

• Analysis of data from 134 histopathologically confirmed CHC patients (HCV RNA-positive, HBsAg-negative, HIV-negative).
• Liver biopsy assessment using Ishak's criteria for grading (necroinflammation) and staging (fibrosis).
• Determination of HLA DRB1 alleles using the INNOLiPA DRB method; statistical analysis of alleles with >10% frequency.

Main Results:

• A statistically significant correlation was observed between DRB1*13 and DRB1*07 alleles and increased necroinflammatory activity.
• The DRB1*13 allele was also significantly associated with the progression of liver disease.
• Conversely, the DRB1*11 allele showed a statistically significant relationship with milder liver damage.

Conclusions:

• Specific HLA class II alleles, particularly DRB1*13, DRB1*07, and DRB1*11, play a role in modulating the immune response and influencing the severity and progression of liver disease in chronic hepatitis C.
• These findings highlight the potential of HLA genotyping for predicting disease outcomes in CHC patients.
• Further research may explore therapeutic strategies targeting HLA-mediated immune responses in CHC.